Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
Kewaunee Scientific
KEQU
$98.9M
| $91.9K | ﹤0.01% |
+2,457
| New | +$99.9K |
2025 Q4
0 quarters
|
|
4527
HireQuest
HQI
$261M
| $91.7K | ﹤0.01% |
8,721
+886
| +11% | +$7.81K |
2023 Q2
10 quarters
|
|
4528
Innovator US Equity Power Buffer ETF April
PAPR
$964M
| $91.6K | ﹤0.01% |
+2,341
| New | +$90.5K |
2025 Q4
0 quarters
|
|
4529
Quantum Corp
QMCO
$1.36B
| $91.6K | ﹤0.01% |
14,197
+13,742
| +3,020% | +$123K |
2020 Q1
23 quarters
|
|
|
ACTU
4530
Actuate Therapeutics
ACTU
$19.7M
| $91.5K | ﹤0.01% |
14,946
+6,081
| +69% | +$41.8K |
2025 Q2
2 quarters
|
|
4531
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.24B
| $91.1K | ﹤0.01% |
+2,000
| New | +$92.4K |
2025 Q4
0 quarters
|
|
4532
Surf Air Mobility
SRFM
$129M
| $89.7K | ﹤0.01% |
46,233
+31,278
| +209% | +$100K |
2025 Q3
1 quarter
|
|
4533
Invesco DB Energy Fund
DBE
$117M
| $89.2K | ﹤0.01% |
+5,105
| New | +$95.3K |
2025 Q4
0 quarters
|
|
4534
Century Casinos
CNTY
$29.3M
| $88.9K | ﹤0.01% |
66,852
-86
| -0.1% | -$154 |
2014 Q3
45 quarters
|
|
4535
Global X Autonomous & Electric Vehicles ETF
DRIV
$362M
| $88.8K | ﹤0.01% |
3,000
| – | – |
2021 Q1
19 quarters
|
|
|
PAMT
4536
PAMT Corp
PAMT
$256M
| $88.6K | ﹤0.01% |
7,337
-1,160
| -14% | -$12.3K |
2017 Q4
32 quarters
|
|
4537
inTEST
INTT
$158M
| $88.5K | ﹤0.01% |
11,846
-19
| -0.2% | -$150 |
2023 Q1
11 quarters
|
|
|
ELVR
4538
Elevra Lithium Ltd
ELVR
$716M
| $86.8K | ﹤0.01% |
1,652
-7
| -0.4% | -$240 |
2025 Q3
1 quarter
|
|
4539
Rhinebeck Bancorp
RBKB
$206M
| $86.7K | ﹤0.01% |
7,210
+778
| +12% | +$8.54K |
2025 Q2
2 quarters
|
|
|
FHDG
4540
FT Vest U.S. Equity Quarterly Dynamic Buffer ETF
FHDG
$76.6M
| $86.4K | ﹤0.01% |
2,546
+1,036
| +69% | +$34.6K |
2024 Q4
4 quarters
|
|
4541
Defiance Quantum ETF
QTUM
$5.81B
| $86K | ﹤0.01% |
+784
| New | +$86.4K |
2025 Q4
0 quarters
|
|
|
TEAD
4542
Teads Holding Co
TEAD
$54.8M
| $85.5K | ﹤0.01% |
121,426
+6,006
| +5% | +$6.36K |
2022 Q1
15 quarters
|
|
4543
Camtek
CAMT
$7.71B
| $85.3K | ﹤0.01% |
802
-4,397
| -85% | -$494K |
2023 Q2
10 quarters
|
|
4544
Neuronetics
STIM
$165M
| $85K | ﹤0.01% |
61,606
+9,941
| +19% | +$20.8K |
2025 Q2
2 quarters
|
|
4545
PUT
Lamb Weston
LW
$5.99B
| $83.8K | ﹤0.01% |
2,000
-523,000
| -100% | -$30.8M |
2024 Q3
5 quarters
|
|
4546
CALL
Charter Communications
CHTR
$12.5B
| $83.5K | ﹤0.01% |
400
| – | – |
2025 Q2
2 quarters
|
|
4547
Banco Santander Chile
BSAC
$15.1B
| $82.9K | ﹤0.01% |
2,666
+2,334
| +703% | +$68K |
2025 Q3
1 quarter
|
|
|
SWKH
4548
DELISTED
SWK Holdings
SWKH
| $82.5K | ﹤0.01% |
4,794
+489
| +11% | +$8.07K |
2022 Q2
14 quarters
|
|
4549
Ispire Technology
ISPR
$79.7M
| $82.4K | ﹤0.01% |
29,433
+2,419
| +9% | +$5.62K |
2023 Q2
10 quarters
|
|
|
NXXT
4550
NextNRG Inc
NXXT
$12.5M
| $81.8K | ﹤0.01% |
5,641
+2,936
| +109% | +$50.6K |
2025 Q1
3 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.